Richard N. Levy, Director at UNIGENE LABORATORIES INC (UGNE), bought 5,000 shares at $0.72 ($4K) on 2010-09-03, disclosed to the SEC on 2010-09-08.
Open-market purchase of $4k UGNE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BKKT | SELL | 2023-12-20 | $956K | — | Filing → |
| BKKT | SELL | 2023-12-19 | $581K | — | Filing → |
| BKKT | SELL | 2023-12-06 | $165K | — | Filing → |